1,039
Views
37
CrossRef citations to date
0
Altmetric
Review

Lactococcus lactis as an adjuvant and delivery vehicle of antigens against pneumococcal respiratory infections

, , , &
Pages 313-325 | Received 29 Nov 2010, Accepted 14 Apr 2010, Published online: 01 Sep 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (36)

Zahra Fatehi, Abbas Doosti & Mohammad Saeid Jami. (2023) Oral vaccination with novel Lactococcus lactis mucosal live vector-secreting Brucella lumazine synthase (BLS) protein induces humoral and cellular immune protection against Brucella abortus. Archives of Microbiology 205:4.
Crossref
Michaela Petaroudi, Aleixandre Rodrigo‐Navarro, Oana Dobre, Matthew J. Dalby & Manuel Salmeron‐Sanchez. (2022) Living Biointerfaces for the Maintenance of Mesenchymal Stem Cell Phenotypes. Advanced Functional Materials 32:32, pages 2203352.
Crossref
Jere Kurkipuro, Igor Mierau, Thomas Wirth, Haritha Samaranayake, Wesley Smith, Hanna-Riikka Kärkkäinen, Mirka Tikkanen & Juha Yrjänheikki. (2022) Four in one—Combination therapy using live Lactococcus lactis expressing three therapeutic proteins for the treatment of chronic non-healing wounds. PLOS ONE 17:2, pages e0264775.
Crossref
Marcela Pereira, Ju Kyoung Oh, Dae-Kyung Kang, Lars Engstrand & Valerie Diane Valeriano. (2022) Hacking Commensal Bacteria to Consolidate the Adaptive Mucosal Immune Response in the Gut–Lung Axis: Future Possibilities for SARS-CoV-2 Protection. BioTech 11:1, pages 3.
Crossref
A Z Mustopa, H H Putri, Kusdianawati, B R Budiarto, A Kusumawati, M Nurfatwa, N Ekawati, A Prastyowati, L Triratna, A Hertati & RN Umami. (2021) Genetic construction of HBsAg gene subgenotype B3 in Lactococcus lactis as hepatitis B vaccine candidate. IOP Conference Series: Earth and Environmental Science 948:1, pages 012071.
Crossref
Nan Qiao, Guangsheng Du, Xiaofang Zhong & Xun Sun. (2021) Recombinant lactic acid bacteria as promising vectors for mucosal vaccination. Exploration 1:2, pages 20210026.
Crossref
Agnieszka Krystyna Wyszyńska & Renata Godlewska. (2021) Lactic Acid Bacteria – A Promising Tool for Controlling Chicken Campylobacter Infection. Frontiers in Microbiology 12.
Crossref
A S Purnomo, I Darti & A Suryanto. (2021) Numerical solution for system with Atangana-Baleanu-Caputo derivative: An influenza epidemic model. Journal of Physics: Conference Series 1968:1, pages 012027.
Crossref
Julio Villena, Chang Li, Maria Guadalupe Vizoso-Pinto, Jacinto Sacur, Linzhu Ren & Haruki Kitazawa. (2021) Lactiplantibacillus plantarum as a Potential Adjuvant and Delivery System for the Development of SARS-CoV-2 Oral Vaccines. Microorganisms 9:4, pages 683.
Crossref
Hong Y Tham, Adelene A-L Song, Khatijah Yusoff & Geok H Tan. (2020) Effect of different cloning strategies in pET-28a on solubility and functionality of a staphylococcal phage endolysin. BioTechniques 69:3, pages 161-170.
Crossref
Diego A. Diaz-Dinamarca, Carlos Hernandez, Daniel F. Escobar, Daniel A. Soto, Guillermo A. Muñoz, Jesús F. Badilla, Ricardo A. Manzo, Flavio Carrión, Alexis M. Kalergis & Abel E. Vasquez. (2020) Mucosal Vaccination with Lactococcus lactis-Secreting Surface Immunological Protein Induces Humoral and Cellular Immune Protection against Group B Streptococcus in a Murine Model. Vaccines 8:2, pages 146.
Crossref
Chandan Gorain, Ankita Singh, Sudipta Bhattacharyya, Anirban Kundu, Aritraa Lahiri, Subhadeep Gupta & Amirul I. Mallick. (2020) Mucosal delivery of live Lactococcus lactis expressing functionally active JlpA antigen induces potent local immune response and prevent enteric colonization of Campylobacter jejuni in chickens. Vaccine 38:7, pages 1630-1642.
Crossref
Sedigheh Taghinezhad-S, Amir Hossein Mohseni, Hossein Keyvani & Mohammad Reza Razavi. (2019) Phase 1 Safety and Immunogenicity Trial of Recombinant Lactococcus lactis Expressing Human Papillomavirus Type 16 E6 Oncoprotein Vaccine. Molecular Therapy - Methods & Clinical Development 15, pages 40-51.
Crossref
Aritraa Lahiri, Shayan Sharif & Amirul Islam Mallick. (2019) Intragastric delivery of recombinant Lactococcus lactis displaying ectodomain of influenza matrix protein 2 (M2e) and neuraminidase (NA) induced focused mucosal and systemic immune responses in chickens. Molecular Immunology 114, pages 497-512.
Crossref
Abdullahi Yusuf, Sania Qureshi, Mustafa Inc, Aliyu Isa Aliyu, Dumitru Baleanu & Asif Ali Shaikh. (2018) Two-strain epidemic model involving fractional derivative with Mittag-Leffler kernel. Chaos: An Interdisciplinary Journal of Nonlinear Science 28:12.
Crossref
G. Georgountzos, C. Michopoulos, C. Grivokostopoulos, M. Kolosaka, N. Vlassopoulou & A. Lekkou. (2018) Infective Endocarditis in a Young Adult due to Lactococcus lactis : A Case Report and Review of the Literature . Case Reports in Medicine 2018, pages 1-4.
Crossref
Isa Abdullahi Baba, Bilgen Kaymakamzade & Evren Hincal. (2018) Two-strain epidemic model with two vaccinations. Chaos, Solitons & Fractals 106, pages 342-348.
Crossref
Nisha Singh, Asheema Vats, Aditi Sharma, Amit Arora & Ashwani Kumar. (2017) The development of lower respiratory tract microbiome in mice. Microbiome 5:1.
Crossref
Agnieszka K. Szczepankowska, Katarzyna Szatraj, Przemysław Sałański, Agnieszka Rózga, Roman K. Górecki & Jacek K. Bardowski. (2017) Recombinant Lactococcus lactis Expressing Haemagglutinin from a Polish Avian H5N1 Isolate and Its Immunological Effect in Preliminary Animal Trials . BioMed Research International 2017, pages 1-8.
Crossref
Ana Fortuna, Gilberto Alves, Ana Serralheiro, Joana Sousa & Amílcar Falcão. (2014) Intranasal delivery of systemic-acting drugs: Small-molecules and biomacromolecules. European Journal of Pharmaceutics and Biopharmaceutics 88:1, pages 8-27.
Crossref
Milene Tavares Batista, Renata D. Souza, Juliano D. Paccez, Wilson B. Luiz, Ewerton L. Ferreira, Rafael C. M. Cavalcante, Rita C. C. Ferreira & Luís C. S. Ferreira. (2014) Gut Adhesive Bacillus subtilis Spores as a Platform for Mucosal Delivery of Antigens. Infection and Immunity 82:4, pages 1414-1423.
Crossref
Elisa O. VintiñiMarcela Medina. (2014) Immune response in nasopharynx, lung, and blood elicited by experimental nasal pneumococcal vaccines containing live or heat-killed lactobacilli as mucosal adjuvants. Canadian Journal of Physiology and Pharmacology 92:2, pages 124-131.
Crossref
Hong-xin Zhang, Yu-yu Qiu, Ying-hui Zhao, Xin-ting Liu, Ming Liu & Ai-lian Yu. (2014) Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant. Molecular and Cellular Probes 28:1, pages 25-30.
Crossref
Shifeng Wang & Roy Curtiss III. (2014) Development of Streptococcus pneumoniae Vaccines Using Live Vectors. Vaccines 2:1, pages 49-88.
Crossref
Paula Gaspar, Ana L. Carvalho, Susana Vinga, Helena Santos & Ana Rute Neves. (2013) From physiology to systems metabolic engineering for the production of biochemicals by lactic acid bacteria. Biotechnology Advances 31:6, pages 764-788.
Crossref
C. Rostagno, P. Pecile & P. L. Stefàno. (2012) Early Lactococcus lactis endocarditis after mitral valve repair: a case report and literature review. Infection 41:4, pages 897-899.
Crossref
Angel Vila-Corcoles & Olga Ochoa-Gondar. (2013) Preventing Pneumococcal Disease in the Elderly. Drugs & Aging 30:5, pages 263-276.
Crossref
Corina Ceapa, Harm Wopereis, Lahcene Rezaïki, Michiel Kleerebezem, Jan Knol & Raish Oozeer. (2013) Influence of fermented milk products, prebiotics and probiotics on microbiota composition and health. Best Practice & Research Clinical Gastroenterology 27:1, pages 139-155.
Crossref
Ana Serralheiro, Gilberto Alves, Joana Sousa, Ana Fortuna & Amílcar Falcão. 2013. Nasal Physiology and Pathophysiology of Nasal Disorders. Nasal Physiology and Pathophysiology of Nasal Disorders 191 215 .
Claire E. Price, Araz Zeyniyev, Oscar P. Kuipers & Jan Kok. (2012) From meadows to milk to mucosa ? adaptation of Streptococcus and Lactococcus species to their nutritional environments . FEMS Microbiology Reviews 36:5, pages 949-971.
Crossref
Bengt Björkstén. (2012) Diverse microbial exposure – Consequences for vaccine development. Vaccine 30:29, pages 4336-4340.
Crossref
G. Gao, J.-J. Qiao, C.-H. Yang, D.-Z. Jiang, R.-Q. Li, J.-J. Su, H.-J. Xu, X.-M. Zhang, Y.-L. Bai & M.-Q. Qiao. (2012) Functional expression of mouse insulin-like growth factor-I with food-grade vector in Lactococcus lactis NZ9000. Letters in Applied Microbiology 54:5, pages 404-409.
Crossref
Hana Farizah Zamri, Mariana Nor Shamsudin, Raha Abdul Rahim & Vasanthakumari Neela. (2012) Oral vaccination with Lactococcus lactis expressing the Vibrio cholerae Wzm protein to enhance mucosal and systemic immunity. Vaccine 30:21, pages 3231-3238.
Crossref
Yongping Ma, Yaolin Luo, Xueping Huang, Fangzhou Song & Geli Liu. (2012) Construction of Bifidobacterium infantis as a live oral vaccine that expresses antigens of the major fimbrial subunit (CfaB) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic Escherichia coli. Microbiology 158:2, pages 498-504.
Crossref
Yong-ping Ma, Ya-ning Hao, Wei Tang, Rong-rong Wang, Fa-ping Yi, You-quan Bu, Lu-yu Zhang & Fang-zhou Song. (2012) Oral Administration Recombinant Bifidobacterium-LTB (B Subunit of Heat-Labile Enterotoxin) Enhances the OVA (Ovalbumin)-Specific sIgA in Jejunal Mucosa of Sprague-Dawley (SD) Rat. International Journal of Clinical Medicine 03:05, pages 387-393.
Crossref
Elisa O Vintiñi & Marcela S Medina. (2011) Host immunity in the protective response to nasal immunization with a pneumococcal antigen associated to live and heat-killed Lactobacillus casei. BMC Immunology 12:1.
Crossref